TLDR
- Igor Cavalcanti tested positive for 19-Norandrosterone after his September 15 knockout victory at Dana White’s Contender Series
- The Nevada Athletic Commission suspended Cavalcanti pending a final ruling on his case
- His manager claims the substance came from medical treatment for a knee injury earlier in 2026
- Cavalcanti allegedly disclosed the nandrolone use to the UFC before his fight
- The 89-second knockout win earned him a UFC contract, but his future with the promotion is now uncertain
Sources: mmafighting.com | mmafighting.com | lufkindailynews.com
Igor Cavalcanti tested positive for a banned substance following his knockout victory at Dana White’s Contender Series on September 15, the Nevada Athletic Commission announced Tuesday. The Brazilian middleweight, who goes by the nickname “Jacare,” defeated Oscar Ravello in just 89 seconds to earn a UFC contract.
The commission found 19-Norandrosterone in Cavalcanti’s system during post-fight testing. He is currently suspended until officials make a final ruling on his case.
UFC signee Igor Cavalcanti (14-2) has been suspended by NSAC for a positive test for 19-Norandrosterone connected to his #DWCS win
Cavalcanti's team tells me it stems from knee injections prior to the DWCS offer and that he had disclosed use. Story headed to @MMAjunkie pic.twitter.com/BTl2I7qOHC
— Nolan King (@mma_kings) November 18, 2026
Fighter Claims Medical Treatment Caused Positive Test
Cavalcanti’s manager Lucas Lutkus released a statement explaining the positive test result. He said the fighter used nandrolone as part of medical treatment for a knee injury.
According to Lutkus, Cavalcanti suffered a medial meniscus tear and cartilage damage in his right knee. His physician prescribed three intramuscular injections of 25 mg between February 21 and March 7, 2026.
The treatment aimed to support muscle recovery and knee stability, according to the manager’s statement. At the time, Cavalcanti was preparing for a fight in Europe and did not know he would compete in the UFC six months later.
Lutkus emphasized that Cavalcanti disclosed his nandrolone use to the UFC before the fight. “Igor had previously disclosed his nandrolone use to the UFC and made no attempt to conceal the treatment,” the statement read.
All In Sports Management began representing Cavalcanti in June 2026, after the medical treatment ended. The management team said they have worked with Cavalcanti and his medical team to gather documentation about the treatment.
UFC Contract Status Remains Unknown
The commission has not decided whether to overturn Cavalcanti’s knockout victory. Officials have not announced what punishment he might face for the positive test.
Cavalcanti’s status with the UFC remains unclear following the failed test. The promotion has not commented on whether his contract will remain valid.
This was Cavalcanti’s second appearance on Dana White’s Contender Series. He first competed on the show in 2024, losing to Seok Hyeon Ko.
After that loss, Cavalcanti won four of his next five fights outside the UFC. His performance earned him another chance on the Contender Series in September.
The quick knockout of Ravello impressed UFC president Dana White enough to offer him a contract. The victory took place at the Meta APEX facility in Las Vegas, Nevada.
The Nevada Athletic Commission will hold a hearing to determine the final outcome of Cavalcanti’s case. The commission will review the medical documentation provided by his team and make a ruling on whether the positive test warrants overturning the result or imposing additional penalties.




>